ArticleInternational journal of clinical oncology2026
Prior response to anti-VEGF agents predicts the efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
Masahiro Hirakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.